From 2011 Pediatric Rheumatology Symposium sponsored by the American College of Rheumatology Miami, FL, USA. 2-5 June 2011
Purpose Patients with Down syndrome (DS) have an increased prevalence of arthritis compared to the general population, and often the arthritis is severe and debilitating. In light of the concern for folate deficiency in this patient population, and a clinically observed increased risk for methotrexate (MTX) toxicity, we investigated intracellular folate concentrations in DS patients on methotrexate therapy.
Methods
This single center cross-sectional study evaluated 102 JIA patients on stable doses of MTX, including 4 DS patients, and 108 patients who were not currently on MTX, including 15 DS patients. After obtaining informed consent, blood was obtained during routine lab monitoring. Clinical data was collected by chart review. RBC folate concentrations were determined after deconjugation and analyzed via reversed phase separation and stable isotope dilution tandem mass spectrometry. Measured intracellular folate isoforms included: 5,10 methenyl tetrahydrofolate (5,10-Methenyl THF) which included the isoforms 5 formyl THF, 10 formyl THF, and 5,10 methenyl THF; 5 methyl tetrahydrofolate (5-MTHF) and the sum of the two. RBC MTX polyglutamate (MTXGlu) concentrations were measured by ion-pair separation followed by tandem mass spectrometry.
Results
In subjects not on MTX therapy, folate concentrations (mean nmol/L (± SD)) tended to be lower in DS patients: 
Conclusion
Despite intracellular folate concentrations being lower in DS patients at baseline, there appears to be no significant folate inhibition by MTX in this population of patients. In our cohort of patients with JIA receiving MTX, those with active arthritis had higher intracellular folate concentrations, suggesting a less effective antifolate effect from MTX. This may also explain the poor response to MTX in our small population of DS patients receiving MTX. However, the number of DS patients receiving MTX in our cohort is small and further assessment in a larger cohort will be necessary to confirm these findings. 
